show episodes
 
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
  continue reading
 
Host Russ Altman, a professor of bioengineering, genetics, and medicine at Stanford, is your guide to the latest science and engineering breakthroughs. Join Russ and his guests as they explore cutting-edge advances that are shaping the future of everything from AI to health and renewable energy. Along the way, “The Future of Everything” delves into ethical implications to give listeners a well-rounded understanding of how new technologies and discoveries will impact society. Whether you’re a ...
  continue reading
 
Artwork

1
MicrobeWorld Video (audio only)

American Society for Microbiology

Unsubscribe
Unsubscribe
Monthly
 
A video podcast by the American Society for Microbiology that highlights the latest in microbiology, life science and biotechnology news. ASM is composed of over 42,000 scientists and health professionals with the mission to advance the microbial sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide. For information about ASM and MicrobeWorld, visit us online at www. ...
  continue reading
 
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something ...
  continue reading
 
Artwork

1
CHI Podcasts

Cambridge Healthtech Podcasts

Unsubscribe
Unsubscribe
Monthly
 
The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.
  continue reading
 
Anna Kavanaugh hosts the weekly radio series, "Mad Science: The Genetic Crossroad." The program aims to raise awareness and provide education about genetically modified organisms (GMO), in the world food supply and the practices of the GM biotech industry. The series is dedicated to all issues surrounding GM foods, its usage and ramifications thereof. Anna is a writer, advocate, and founder of the (AKCF) Anna Kavanaugh Charitable Foundation. Her original novel, "The Cord of Callows," now an ...
  continue reading
 
Sounds of Science is a monthly podcast about beginnings: how a molecule becomes a drug, how a rodent elucidates a disease pathway, how a horseshoe crab morphs into an infection fighter. The podcast is produced by Eureka, the scientific blog of Charles River, a contract research organization for drug discovery and development. Tune in and begin the journey.
  continue reading
 
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
  continue reading
 
Artwork

1
Biologize

Phil Richardson

Unsubscribe
Unsubscribe
Monthly
 
Dr Phil Richardson explores how to solve complex problems in strategy, innovation and change management using business models created from biological systems. Based on 3.8 billion years of evolution biological systems can provide a unique, if not counterintuitive way of thinking differently. The approach has been successfully used in product and service development, creating new ways of working, improving collaboration and delivering disruptive change.
  continue reading
 
Loading …
show series
 
While existing immunotherapies have changed cancer care, there are several types of cancer where they have limited or no efficacy. Pheast Therapeutics is addressing that by looking to macrophages, part of the innate immune system. These white blood cells gobble up pathogens, cancer cells, and other foreign substances. Certain tumors, though, can ev…
  continue reading
 
As researchers continue to look for new ways to test therapeutics in vitro, the field of biomedical engineering is offering new microphysiological systems that can reduce the need for animal models. Hear from Jeffrey Borenstein, Director of the Biomedical Engineering Centre at Draper, as he explains how it works, ways to expedite its access, and th…
  continue reading
 
n this episode, Dr. Kevin Folta speaks with Joe Damond about the rapidly evolving landscape of life sciences, particularly focusing on gene and cell therapies. They discuss the exciting advancements in medical technology, the economic challenges associated with developing new therapies, and the implications for healthcare systems and patient access…
  continue reading
 
n this episode, Dr. Kevin Folta speaks with Joe Damond about the rapidly evolving landscape of life sciences, particularly focusing on gene and cell therapies. They discuss the exciting advancements in medical technology, the economic challenges associated with developing new therapies, and the implications for healthcare systems and patient access…
  continue reading
 
Climate change authority Noah Diffenbaugh says that the effects of climate change are no longer theoretical but apparent in everyday, tangible ways. Still, he says, it is not too late to better understand the effects of climate change, to mitigate them through reductions in greenhouse gas emissions and other measures, and to adapt how we live in th…
  continue reading
 
About 98 percent of the the human genome consists of non-protein coding regions known as the “dark genome.” Once derided as “junk DNA,” these regions are increasingly understood to play a critical role in the regulation of the genome and offer a novel means of targeting diseases. Haya Therapeutics is exploring long non-coding RNAs as potential ther…
  continue reading
 
In this episode of the Talking Biotech podcast, Kevin Folta interviews Jenny Du, co-founder and senior vice president of operations at Apeel, a company focused on reducing food waste through innovative post-harvest technology. They discuss the significant issue of food waste, particularly in fresh produce, and how Apeel's products work to extend th…
  continue reading
 
In this episode of the Talking Biotech podcast, Kevin Folta interviews Jenny Du, co-founder and senior vice president of operations at Apeel, a company focused on reducing food waste through innovative post-harvest technology. They discuss the significant issue of food waste, particularly in fresh produce, and how Apeel's products work to extend th…
  continue reading
 
Climate modeler Aditi Sheshadri says that while weather forecasting and climate projection are based on similar science, they are very different disciplines. Forecasting is about looking at next week, while projection is about looking at the next century. Sheshadri tells host Russ Altman how new data and techniques, like low-cost high-altitude ball…
  continue reading
 
One of the promises of AI is to redefine what’s possible by enabling the discovery of compounds that exist in a much larger chemical space than scientists have previously been able to explore. Deepcure is using AI and physics to discover small molecule therapies that can bind to difficult to target proteins. We spoke to Kfir Schreiber, co-founder a…
  continue reading
 
I am joined by Raphael (Ralph) Malbrue, Director & Attending Veterinarian, Center for Comparative Medicine, University of Virginia; and Christina (Winnie) Winnicker, Executive Director for Laboratory Animal Medicine for Charles River. Both bring a fresh perspective to the questions of how to improve diversity in veterinary medicine, how to inform n…
  continue reading
 
Halloween may be behind us in the US but here at The Future of Everything we’re not quite done with spooky season. If you’re pairing your trick-or-treat haul with some scary movies, we invite you to revisit with us a conversation Russ had with Lawrence Wein a couple years ago about the work he’s doing in forensic genetic genealogy to crack cold cas…
  continue reading
 
The BET family of proteins regulates gene expression. Their overexpression has been implicated in both cancer and inflammatory diseases. Vyne Therapeutics is developing oral and topical BET inhibitors that treat inflammatory conditions ranging from rheumatoid arthritis to the skin condition vitiligo. We spoke to Vyne CEO David Domzalski and Vyne Ch…
  continue reading
 
Returning guest Marco Pavone is an expert in autonomous robotic systems, such as self-driving cars and autonomous space robots. He says that there have been major advances since his last appearance on the show seven years ago, mostly driven by leaps in artificial intelligence. He tells host Russ Altman all about the challenges and progress of auton…
  continue reading
 
In August, the U.S. Food and Drug Administration approved Adaptimmune’s Tecelra, the first engineered cell therapy to treat a solid tumor. The T cell receptor gene therapy is approved to treat synovial sarcoma, a rare soft tissue cancer that most often affects young adults. We spoke to Adrian Rawcliffe, CEO of Adaptimmune, about the approval, how T…
  continue reading
 
Citrus greening disease or HLB has severely impacted Florida citrus production. And while many solutions have been proposed, there is interest in a number of trees that have shown to not show symptoms of the disease. This week's episode discusses the disease with retired extension specialist Gary England as he evaluates "survivor" trees. These tree…
  continue reading
 
Citrus greening disease or HLB has severely impacted Florida citrus production. And while many solutions have been proposed, there is interest in a number of trees that have shown to not show symptoms of the disease. This week's episode discusses the disease with retired extension specialist Gary England as he evaluates "survivor" trees. These tree…
  continue reading
 
Physicist Matthias Kling studies photons and the things science can do with ultrafast pulses of X-rays. These pulses last just attoseconds – a billionth of a billionth of a second, Kling says. He uses them to create slo-mo “movies” of electrons moving through materials like those used in batteries and solar cells. The gained knowledge could reshape…
  continue reading
 
Hibernation is not just a matter of deep sleep. Animals that hibernate are able to do so without suffering damage to tissue and muscle. Understanding the biology of hibernation can unlock potential insights into obesity, heart attack and stroke, muscle atrophy, neuroprotection, and longevity. Fauna Bio is studying genomic data from so-called "extre…
  continue reading
 
Piotr Kosla, founder of the PACS2 Research Foundation, joins us to discuss his personal motivation to develop the first treatment for Development and Epileptic Encephalopathy 66 (PACS2 Syndrome), how cell painting assays are being used to repurpose a treatment for this condition, what the future holds for research in this area, and how you can help…
  continue reading
 
In this conversation, Dr. Kevin Folta and Vance Crowe discuss the evolving landscape of agriculture communication, the rise of pseudoscience, and the cultural shifts affecting public trust in science. Vance shares his journey from working at Monsanto to founding Legacy Interviews, emphasizing the importance of capturing personal stories. They explo…
  continue reading
 
In this conversation, Dr. Kevin Folta and Vance Crowe discuss the evolving landscape of agriculture communication, the rise of pseudoscience, and the cultural shifts affecting public trust in science. Vance shares his journey from working at Monsanto to founding Legacy Interviews, emphasizing the importance of capturing personal stories. They explo…
  continue reading
 
We’re just weeks away from a national election, and in our polarized society, we all know it can be difficult to find and create spaces for thoughtful policy discussions. A couple of years ago, James Fishkin, a professor of communication at Stanford, joined the podcast. He talked about a system called deliberative polling that can serve as a model …
  continue reading
 
Senescent cells, ones that no longer divide but are metabolically active, are associated with aging. They are also implicated in a broad range of aging-related diseases including cancer, diabetes, and neurodegenerative conditions. In the case of cancer, these cells can help protect tumors from a person’s immune system. Immorta Bio is seeking to add…
  continue reading
 
Protein is essential for normal human development and physiology, yet is a significant global deficiency. World food staple crops like rice, wheat, cassava, and potato have relatively protein levels, yet constitute a significant portion of calories consumed. Dr. Ling Li of Mississippi State University has identified that overexpression of a gene ca…
  continue reading
 
Protein is essential for normal human development and physiology, yet is a significant global deficiency. World food staple crops like rice, wheat, cassava, and potato have relatively protein levels, yet constitute a significant portion of calories consumed. Dr. Ling Li of Mississippi State University has identified that overexpression of a gene ca…
  continue reading
 
Astronautics professor Grace Gao is an authority on the Global Positioning System. GPS has long been key to navigation on Earth, she says, but science is now shifting its focus outward to the frontiers of space. Gao is working on a GPS-like system for the Moon. To keep costs low, this lunar positioning system will leverage Earth-based satellites co…
  continue reading
 
From cell to cell within a given tissue, variability exists. Single-cell sequencing technologies from 10X Genomics is helping researchers and drug developers understand cellular diversity in tissue once thought to be made up of homogenous populations. This has the potential to lead to new understandings of diseases, open up new targets for drug dev…
  continue reading
 
Lisa Sharp, Project Coordinator for Charles River, joins us to discuss her COVID lockdown experience. Right at the beginning of the pandemic, just weeks apart, both she and her husband were diagnosed with cancer. Sadly, he didn't make it. While Lisa and their daughter faced the worst, she decided to make big changes to her life and career. Listen n…
  continue reading
 
Sports medicine physician Emily Kraus knows a lot about the health challenges of female athletes. Women face far more ACL tears and bone stress injuries than men, for instance, and excessive training or poor nutrition can also delay puberty and affect menstruation. These differences are vastly understudied, she says. To close the gap, Kraus initiat…
  continue reading
 
The DDR pathway plays a critical role in repairing DNA damage in healthy cells that would otherwise cause mutations or cell death. When this pathway is altered and becomes unable to repair this damage, mutated cells can grow out of control and become cancerous. They can also be more resistant to standard chemotherapies and radiation. Aprea Therapeu…
  continue reading
 
Nearly 70 percent of patients with chronic conditions fail to take their medicines as prescribed. This can lead to poor outcomes and greater healthcare costs. Vivani Medical, which has developed implantable drug delivery technology, said it can provide steady drug release for up to six months with a single implant. This not only can address the pro…
  continue reading
 
Today, we’re bringing you a best-of from our archive of over 250 episodes. We’re all aware that the consequences of climate change range from rising sea levels, to drought, wildfires, economic disruption and the displacement of populations. We’re seeing and living through many of these effects, but is there hope for managing additional risk? A coup…
  continue reading
 
Imagine you’re exploring the great outdoors when, out of nowhere, you feel the fangs of a snake – a poisonous snake – breaking through your skin. Medical care is nowhere in sight, so you’re left with the terrifying prospect of venom slowly infecting your body’s critical functions. This is the reality that roughly five million people face annually. …
  continue reading
 
Taken any selfies lately? Dermatologist Zakia Rahman studies both the science of healthy skin and the effects of the exponential increase in skin images on self-esteem. As a result, skin health is linked to mental health, she says. It’s not about vanity, it’s about vitality, Rahman tells host Russ Altman on this episode of Stanford Engineering’s Th…
  continue reading
 
One of the key obstacles to developing new drugs and diagnostics is the lack of access to longitudinal biological and clinical patient data. Culmination Bio, a spin-out of Intermountain Health, is building the largest patient data platform with more than 40 years of de-identified patient electronic health records and biospecimen data. We spoke to L…
  continue reading
 
Arvind Karunakaran studies the intersections of work, AI, and organizational behavior. He says AI can enhance speed and productivity in the short run, yet degrade skills over time. But it is in organizational power dynamics where AI has had its most marked impact, he says, telling host Russ Altman about situations in law firms where AI has fostered…
  continue reading
 
NAMPT is a critical enzyme that regulates how cells use energy. It can also play an important role in the ability of cancer cells to survive, grow, and spread. While it’s been recognized as a potential target to treat certain cancers, developing NAMPT inhibitors have been challenging because they can disrupt energy metabolism in healthy cells. Reme…
  continue reading
 
We want to wish our listeners in the states a happy Labor Day weekend. We hope, wherever you are, you’re taking some time to savor the last bit of summer. After a couple months full of travel and news about the airplane industry, we can’t help wondering — are there better ways to build airplanes? Our previous guest, Ilan Kroo, an expert in aeronaut…
  continue reading
 
The emergence of CRISPR, a powerful tool for gene editing, promises to correct devastating genetic diseases, but it also raises concerns about how it will be used and who will make those decisions. Neal Baer, in his new book “The Promise and Peril of CRISPR,” brings together a series of essays by bioethicists, geneticists, and others who explore et…
  continue reading
 
Political scientist Kathryn Stoner is the Director of the Center on Democracy, Development and the Rule of Law (CDDRL) at Stanford and an authority on Russian/Ukrainian politics. She says views on the current war depend on which side someone is on: Many Russians and their leader Vladimir Putin say Ukrainians are Russians and have been since the 10t…
  continue reading
 
Speeding Protein Engineering with Whether it’s the development of new biotherapeutics, or replacing hydrocarbons from their role in industrial manufacturing, engineering proteins suited for a task is a time consuming and expensive process. Cradle Bio has developed generative AI technology to accelerate protein engineering by reducing the number of …
  continue reading
 
We regularly discuss a small suite of commercial crops that have been genetically enhanced with transgenes. However, one additional genotype was transformed long ago, and approved for use in the USA, Canada and EU-- but nobody talks about it much. It is the plum resistant to plum pox virus (PPV), a devastating virus of stonefruits. While rare in th…
  continue reading
 
We regularly discuss a small suite of commercial crops that have been genetically enhanced with transgenes. However, one additional genotype was transformed long ago, and approved for use in the USA, Canada and EU-- but nobody talks about it much. It is the plum resistant to plum pox virus (PPV), a devastating virus of stonefruits. While rare in th…
  continue reading
 
Dan Schwartz is a cognitive psychologist and dean of the Stanford Graduate School of Education. He says that artificial intelligence is a different beast, but he is optimistic about its future in education. “It’s going to change stuff. It’s really an exciting time,” he says. Schwartz imagines a world not where AI is the teacher, but where human stu…
  continue reading
 
Loading …

Quick Reference Guide